Header cover image
  • Investing Ideas
  • Palestinian Software Transformative Artificial intelligence (AI) Healthcare Stocks

Palestinian Software Transformative Artificial intelligence (AI) Healthcare Stocks

Results

130

4 new

Artificial intelligence (AI) is set to transform healthcare by enhancing diagnostics, personalizing medicine, boosting operational efficiency, expanding remote care, and accelerating research. AI outperforms humans in detecting diseases like cancer from scans, tailors treatments using genetic and lifestyle data, and streamlines hospital workflows with tools like predictive analytics and automated transcription. It powers telemedicine, monitors chronic conditions in real-time, and speeds up drug discovery by analyzing vast datasets for insights into complex diseases. Despite challenges like data privacy, bias, and integration costs, AI’s ability to improve accuracy, access, and affordability could save billions and extend lives, marking a seismic shift in healthcare delivery and outcomes.

130 companies

Medtronic

Market Cap: US$118.1b

Develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.

MDT

US$93.35

7D

2.3%

1Y

0.7%

Pfizer

Market Cap: US$158.4b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

PFE

US$28.07

7D

4.8%

1Y

8.5%

Healwell AI

Market Cap: CA$234.5m

Operates as a healthcare technology company in Canada, Australia, and New Zealand.

AIDX

CA$0.79

7D

5.3%

1Y

-43.2%

Telescope Innovations

Market Cap: CA$39.2m

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.

TELI

CA$0.59

7D

37.2%

1Y

78.8%

Eastwood Bio-Medical Canada

Market Cap: CA$134.3m

Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia.

EBM

CA$1.70

7D

-5.6%

1Y

466.7%

CorVel

Market Cap: US$3.5b

Provides workers’ compensation, general and auto liability, and hospital bill auditing and payment integrity solutions.

CRVL

US$70.15

7D

6.7%

1Y

-24.3%

Xlife Sciences

Market Cap: CHF 86.1m

Focuses on the development and commercialization of research projects in the life sciences sector.

XLS

CHF 15.20

7D

-6.7%

1Y

-26.9%

Axe Compute

Market Cap: US$111.2m

Provides access to graphics processing unit and digital asset treasury strategy.

AGPU

US$10.21

7D

23.5%

1Y

-26.8%

Medical Care Technologies

Market Cap: US$389.3k

Operates in the collectibles and memorabilia industry.

MDCE

US$0.00015

7D

-25.0%

1Y

-50.0%

GENOVA

Market Cap: JP¥10.8b

Engages in the medical platform and smart clinic businesses in Japan.

9341

JP¥625.00

7D

1.5%

1Y

-4.0%

Beijing Airdoc Technology

Market Cap: HK$1.1b

Provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions in Mainland China and internationally.

2251

HK$10.40

7D

13.7%

1Y

-19.4%

Singular Health Group

Market Cap: AU$57.0m

A medical technology company, engages in the development and provision of 3DiCom software medical technology in Australia.

SHG

AU$0.18

7D

-2.7%

1Y

-42.9%

HBM Holdings

Market Cap: HK$13.8b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

2142

HK$15.90

7D

5.3%

1Y

27.8%

Truking Technology

Market Cap: CN¥6.4b

Engages in medical equipment business in China and internationally.

300358

CN¥9.00

7D

-1.4%

1Y

1.5%

Oncotelic Therapeutics

Market Cap: US$17.6m

A clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications in the United States.

OTLC

US$0.037

7D

-14.9%

1Y

-26.1%

Poolbeg Pharma

Market Cap: UK£68.7m

A clinical-stage biopharmaceutical company, engages in developing immunotherapy for cancer in the United Kingdom.

POLB

UK£0.088

7D

3.5%

1Y

188.5%

LataMed AI

Market Cap: US$112.3m

A development-stage technology company focused on the research, development, and commercialization of facial recognition technology solutions.

LMED

US$0.48

7D

-14.4%

1Y

556.5%

Light AI

Market Cap: CA$25.1m

A healthcare technology company, focuses on the development of artificial intelligence and machine learning diagnostic digital healthcare solutions.

ALGO

CA$0.20

7D

-14.6%

1Y

-29.3%

GENINUS

Market Cap: ₩78.8b

A bioinformation analysis company, engages in the research and development, manufacture, and sale of genome analysis solutions in South Korea, the United States, and Asia.

A389030

₩2,000.00

7D

-9.7%

1Y

27.2%

Memphasys

Market Cap: AU$18.5m

Develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia.

MEM

AU$0.006

7D

-14.3%

1Y

50.0%

aetherAI

Market Cap: NT$1.9b

Provides medical image AI solution in Taiwan, Japan, and Germany.

7803

NT$19.60

7D

-0.5%

1Y

-34.7%

AmCad BioMed

Market Cap: NT$696.7m

Develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan.

4188

NT$11.00

7D

9.5%

1Y

-26.4%

Hi-CRATESLTD

Market Cap: JP¥5.1b

Engages in the research, development, sales, and support of integrated dental electronic medical record systems.

4172

JP¥2,291.00

7D

0.6%

1Y

-1.3%

Algorae Pharmaceuticals

Market Cap: AU$22.3m

A pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand.

1AI

AU$0.011

7D

0%

1Y

22.2%

OneMedNet

Market Cap: US$32.3m

A healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East.

ONMD

US$0.60

7D

-23.2%

1Y

-23.1%

TrivarX

Market Cap: AU$17.3m

A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.

TRI

AU$0.015

7D

7.1%

1Y

50.0%

PRISM BioLabLTD

Market Cap: JP¥6.3b

Engages in the research and development of pharmaceuticals using its proprietary drug discovery platform technology, PepMetics Technology.

206A

JP¥170.00

7D

2.4%

1Y

-5.0%

G3 Global Berhad

Market Cap: RM 41.5m

An investment holding company, provides information and communication technology in Malaysia.

G3

RM 0.01

7D

-33.3%

1Y

-50.0%

Resonance Health

Market Cap: AU$28.6m

A healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa.

RHT

AU$0.06

7D

13.2%

1Y

30.4%

Genetics Generation Advancement

Market Cap: NT$1.1b

Engages in the development and implementation of digital data management systems for gene testing, biological, chemical, and materials information in Taiwan.

4160

NT$39.50

7D

-0.8%

1Y

-25.3%

Milton Essex Spólka Akcyjna

Market Cap: zł46.3m

Designs, develops, manufactures, and sells medical devices, instruments, and products in Poland.

MTN

zł0.68

7D

-3.6%

1Y

-6.3%

Identi Healthcare

Market Cap: ₪25.9m

Provides healthcare inventory management systems.

IDNT

₪1.76

7D

0.2%

1Y

-23.3%

Medimaging Integrated Solution

Market Cap: NT$2.6b

Engages in the design, manufacture and sale of digital medical imaging diagnostic equipments.

6796

NT$65.30

7D

8.7%

1Y

-11.2%

JLK

Market Cap: ₩118.9b

Provides diagnosis support to the patients with its AI-driven medical platform in South Korea.

A322510

₩4,685.00

7D

-9.9%

1Y

-16.2%

Ever Fortune.AI

Market Cap: NT$5.0b

An cloud-based biomedical platform, provides medical artificial intelligence (AI) solutions and services in China.

6841

NT$53.00

7D

-0.4%

1Y

-24.3%

IGC Pharma

Market Cap: US$28.7m

A clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer’s disease in the United States and Colombia.

IGC

US$0.31

7D

3.4%

1Y

-15.6%

Page 3 of 4